Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan-Dec:23:15330338241259633.
doi: 10.1177/15330338241259633.

A Beam Angle Selection Method to Improve Plan Robustness Against Position Error in Intensity-Modulated Radiotherapy for Left-Sided Breast Cancer

Affiliations

A Beam Angle Selection Method to Improve Plan Robustness Against Position Error in Intensity-Modulated Radiotherapy for Left-Sided Breast Cancer

Zhen Ding et al. Technol Cancer Res Treat. 2024 Jan-Dec.

Abstract

Purpose: We report a dosimetric study in whole breast irradiation (WBI) of plan robustness evaluation against position error with two radiation techniques: tangential intensity-modulated radiotherapy (T-IMRT) and multi-angle IMRT (M-IMRT).

Methods: Ten left-sided patients underwent WBI were selected. The dosimetric characteristics, biological evaluation and plan robustness were evaluated. The plan robustness quantification was performed by calculating the dose differences (Δ) of the original plan and perturbed plans, which were recalculated by introducing a 3-, 5-, and 10-mm shift in 18 directions.

Results: M-IMRT showed better sparing of high-dose volume of organs at risk (OARs), but performed a larger low-dose irradiation volume of normal tissue. The greater shift worsened plan robustness. For a 10-mm perturbation, greater dose differences were observed in T-IMRT plans in nearly all directions, with higher ΔD98%, ΔD95%, and ΔDmean of CTV Boost and CTV. A 10-mm shift in inferior (I) direction induced CTV Boost in T-IMRT plans a 1.1 (ΔD98%), 1.1 (ΔD95%), and 1.7 (ΔDmean) times dose differences greater than dose differences in M-IMRT plans. For CTV Boost, shifts in the right (R) and I directions generated greater dose differences in T-IMRT plans, while shifts in left (L) and superior (S) directions generated larger dose differences in M-IMRT plans. For CTV, T-IMRT plans showed higher sensitivity to a shift in the R direction. M-IMRT plans showed higher sensitivity to shifts in L, S, and I directions. For OARs, negligible dose differences were found in V20 of the lungs and heart. Greater ΔDmax of the left anterior descending artery (LAD) was seen in M-IMRT plans.

Conclusion: We proposed a plan robustness evaluation method to determine the beam angle against position uncertainty accompanied by optimal dose distribution and OAR sparing.

Keywords: beam angle; intensity-modulated radiotherapy; left-sided breast; position-error; robustness.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Beam arrangements of T-IMRT and M-IMRT plans. (A). T-IMRT; (B) M-IMRT.
Figure 2.
Figure 2.
Steps in robustness evaluation of T-IMRT and M-IMRT plans.
Figure 3.
Figure 3.
A sample of dose-volume histograms (DVHs) of the nominal and perturbed T-IMRT and M-IMRT plans for different isocenter shifts. (A) PTV of T-IMRT plans with a 3-mm shift; (B) PTV of T-IMRT plans with a 5-mm shift; (C) PTV of T-IMRT plans with a 10-mm shift; (D) PTV of M-IMRT plans with a 3-mm shift; (E) PTV of M-IMRT plans with a 5-mm shift; (F) PTV of M-IMRT plans with a 10-mm shift; (G) PTV Boost of T-IMRT plans with a 3-mm shift; (H) PTV Boost of T-IMRT plans with a 5-mm shift; (I) PTV Boost of T-IMRT plans with a 10-mm shift; (J) PTV Boost of M-IMRT plans with a 3-mm shift; (K) PTV Boost of M-IMRT plans with a 5-mm shift; (L) PTV Boost of M-IMRT plans with a 10-mm shift; PTV, plan target volume; PTV Boost, plan target volume boost; T-IMRT, tangential intensity-modulated radiation; M-IMRT, multiple-angle intensity-modulated radiation. L, left; R, right; A, anterior; P, posterior; S, superior; I, inferior.
Figure 4.
Figure 4.
TCP reduction (ΔTCP) of CTV and CTV Boost between the reference and perturbed T-IMRT and M-IMRT plans for different isocenter shifts. (A). ΔTCP of CTV (3 mm); (B). ΔTCP of CTV (5 mm); (C) ΔTCP of CTV (10 mm); (D). ΔTCP of CTV Boost (3 mm); (E). ΔTCP of CTV Boost (5 mm); (F) ΔTCP of CTV Boost (10 mm).
Figure 5.
Figure 5.
Dose difference between the reference and perturbed T-IMRT and M-IMRT plans for different isocenter shifts. (A) ΔV20 of Lung L; (B) ΔV5 of Lung L; (C) ΔDmean of Lung L; (D) EUD of Lung L; (E) ΔV20 of heart; (F) ΔV5 of heart; (G) ΔDmean of heart; (H) EUD of heart; (I) ΔDmean of Lung R; (J) ΔDmean of Breast R; (K) ΔDmax of LAD; (L) ΔDmean of LAD.

References

    1. Xiang X, Ding Z, Feng L, Li N. A meta-analysis of the efficacy and safety of accelerated partial breast irradiation versus whole-breast irradiation for early-stage breast cancer. Radiat Oncol. 2021;16(1):24. doi:10.1186/s13014-021-01752-2. - DOI - PMC - PubMed
    1. Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14(11):1086‐1094. doi:10.1016/S1470-2045(13)70386-3 - DOI - PubMed
    1. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513‐520. doi:10.1056/NEJMoa0906260 - DOI - PubMed
    1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707‐1716. doi:10.1016/S0140-6736(11)61629-2 - DOI - PMC - PubMed
    1. Bantema-Joppe EJ, Vredeveld EJ, de Bock GH, et al. Five year outcomes of hypofractionated simultaneous integrated boost irradiation in breast conserving therapy; patterns of recurrence. Radiother Oncol. 2013;108(2):269‐272. doi:10.1016/j.radonc.2013.08.037 - DOI - PubMed

MeSH terms